Abstract Details

Title Occipital Nerve Blocks: Effect of Symptomatic Medication Overuse and Headache Type on Failure Rate

Topic Headache

Presentation(s) (-)

Poster/Presentation
Number 169

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Joshua Tobin, MD, FAAN (Banner University Medical Center Neurosciences Institute)	An immediate family member of Dr. Tobin has received personal compensation for serving as an employee of Amgen. Dr. Tobin has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eli Lilly. Dr. Tobin has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for AbbVie.
	No disclosure on file
Stephen S. Flitman, MD (Xenoscience)	No disclosure on file
	No disclosure on file

��ɫ����